Key result
Neuroleptic malignant syndrome is a serious condition associated with dopamine antagonists that requires high clinical suspicion, immediate drug discontinuation, and individualized supportive care.
Population
Patients with or at risk for Neuroleptic malignant syndrome (NMS)
Design
Review
Authors
Loading...
Alerts clinicians to NMS signs with antipsychotics; leaves open dopamine-targeted interventions pending higher-level evidence.
NMS is a life-threatening condition requiring high clinical suspicion, immediate withdrawal of offending agents, and individualized supportive or pharmacologic therapy.
Ananth et al. (2004) conducted a review in Neuroleptic malignant syndrome. Neuroleptic malignant syndrome is a serious condition associated with dopamine antagonists that requires high clinical suspicion, immediate drug discontinuation, and individualized supportive care.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: